High expression of ERCC1, FLT1, NME4 and PCNA associated with poor prognosis and advanced stages in myelodysplastic syndrome

Leukemia and Lymphoma

Volumn 49, Issue 7, 2008, Pages 1297-1305

  Kracmarova, Alzbeta ^a   Cermak, Jaroslav ^a   Brdicka, Radim ^a   Bruchova, Hana ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

ERCC1; FLT1; Gene expression; Myelodysplastic syndrome; NME4; PCNA

Indexed keywords

B RAF KINASE; CELL ANTIGEN; COLONY STIMULATING FACTOR 1; COMPLEMENTARY DNA; CYCLIN H; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; INTERLEUKIN 13; INTERLEUKIN 6 RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN ASSOCIATED PROTEIN; METALLOPROTEINASE INHIBITOR; NUCLEOSIDE DIPHOSPHATE KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN BCL 2; PROTEIN NME4; PROTEIN TNFSF25; RETINOID X RECEPTOR ALPHA; RIBOSOME PROTEIN; RIBOSOME PROTEIN SA; SEPTIN; SEPTIN 7; TIMP METALLOPROTEINASE INHIBITOR; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; VASCULOTROPIN RECEPTOR 1;

5Q- SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE EXACERBATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 47649094853     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802129918     Document Type: Article

References (27)

1. Cazzola, M. and Malcovati, L. (2005) Myelodysplastic syndromes - coping with ineffective hematopoiesis. N Engl J Med, 352, pp. 536-538.
2. Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P. Sanz, G. et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, pp. 2079-2088.
3. Gallagher, A., Darley, R. L. and Padua, R. (1997) The molecular basis of myelodysplastic syndromes. Haematologica, 82, pp. 191-204.
4. Solé, F., Espinet, B., Sanz, G. F., Cervera, J., Calasanz, M. J. Luño, E. et al. (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromesGrupo Cooperativo Espanol de Citogenética Hematológica. Br J Haematol, 108, pp. 346-356.
5. Miyazato, A., Ueno, S., Ohmine, K., Ueda, M., Yoshida, K. Yamashita, Y. et al. (2001) Identification of myelodysplastic syndrome-specific genes by DNS microarray analysis with purified hematopoietic stem cell fraction. Blood, 98, pp. 422-427.
6. Pellagatti, A., Esoof, N., Watkins, F., Langford, C. F., Vetrie, D. Campbell, L. J. et al. (2004) Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Br J Haematol, 125, pp. 576-583.
7. Pellagatti, A., Cazzola, M., Giagounidis, A AN, Malcovati, L., Porta, M GD Killick, S. et al. (2006) Gene expression profiles of CD34+ cells in myelodysplastic syndromes: Involvement of interferon stimulated genes an correlation to FAB subtype and karyotype. Blood, 108, pp. 337-345.
8. Hofmann, W. K., de Vos, S., Komor, M., Hoelzer, D., Wachsman, W. and Koeffler, H. P. (2002) Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood, 100, pp. 3553-3560.
9. Chen, G., Zeng, W., Miyazato, A., Billings, E., Maciejewski, J. P. Kajigaya, S. et al. (2004) Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood, 140, pp. 4210-4218.
10. Nilsson, L., Eden, P., Olsson, E., Mansson, R., Astrand-Grundstrom, I. Strombeck, B. et al. (2007) The molecular signature of MDS stem cells supports a stem cell origin of 5q-myelodysplastic syndromes. Blood, 110, pp. 3005-3014.
11. Ueda, M., Ota, J., Yamashita, Y., Choi, Y. L., Ohki, R. Wada, T. et al. (2003) DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome. Br J Haematol, 123, pp. 288-296.
12. Chomczynsky, P. and Sacchi, N. (1987) Single step Metod of RNA isolation by acid quanidin-isothiocyanate-phenol-chloroform extraction. Anal Biochem, 162, pp. 156-159.
13. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, pp. 402-408.
14. Ito, M., Tsurusawa, M., Zha, Z., Kawai, S., Takasaki, Y. and Fujimoto, T. (1992) Cell proliferation in childhood acute leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis. Cancer, 69, pp. 2176-2182.
15. Okabe-Kado, J. (2002) Serum nm23-H1 protein as a prognostic factor in hematological malignancies. Leuk Lymphoma, 43, pp. 859-867.
16. Hayer, J., Engel, M., Seifert, M., Seitz, G. and Welter, C. (2001) Overexpression of nm23-H4 RNA in colorectal and renal tumours. Anticancer Res, 21, pp. 2821-2825.
17. Seifert, M., Welter, C., Mehraein, Y. and Seitz, G. (2005) Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer. J Pathol, 205, pp. 623-632.
18. Verstovsek, S., Estey, E., Manshouri, T., Giles, F. J., Cortes, J. Beran, M. et al. (2002) Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome. Br J Haematol, 118, pp. 151-156.
19. Hu, Q., Dey, A. L., Yang, Y., Shen, Y., Jilani, I. B. Estey, E. H. et al. (2004) Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer, 100, pp. 1884-1891.
20. Wierzbowska, A., Robak, T., Wrzesień-Kuś, A., Krawczynska, A., Lech-Marańda, E. and Urbańska-Ryś, H. (2003) Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia. Eur Cytokine Network, 14, pp. 149-153.
21. Azuma, K., Komohara, Y., Sasada, T., Terazaki, Y., Ikeda, J. Hoshino, T. et al. (2007) Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Sci, 98, pp. 1336-1343.
22. Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., Andre, F. Haddad, V. et al. (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med, 355, pp. 983-991.
23. Bruchova, H., Kalinova, M. and Brdicka, R. (2004) Array-based analysis of gene expression in childhood acute lymphoblastic leukemia. Leuk Res, 28, pp. 1-7.
24. Giglio, A., Drach, J., Kornblau, S. M., Patel, S., Novaes, M. Khetan, R. et al. (1995) Quantitive expression of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induciton in patients with acute myelogenous leukemia. Leuk Lymphoma, 19, pp. 235-241.
25. Orazi, A., Albitar, M., Heerema, N. A., Haskins, S. and Neiman, R. S. (1997) Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol, 107, pp. 268-274.
26. Kitagawa, M., Kamiyama, R. and Kasuga, T. (1993) Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum Pathol, 24, pp. 359-363.
27. Alexandrakis, M. G., Passam, F. H., Dambaki, K., Passam, A. M., Nalbanti, F. Stathopoulos, E. S. et al. (2005) The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance. Eur J Histochem, 49, pp. 27-32.